False-negative testing for severe acute respiratory syndrome coronavirus 2: consideration in obstetrical care.
Am J Obstet Gynecol MFM
; 2(3): 100130, 2020 08.
Article
in English
| MEDLINE | ID: covidwho-1064733
ABSTRACT
Because the obstetrical population seems to have a high proportion of asymptomatic patients who are carriers of severe acute respiratory syndrome coronavirus 2, universal testing has been proposed as a strategy to risk-stratify all obstetrical admissions and guide infection prevention protocols. Here, we describe a case of a critically ill obstetrical patient with all the clinical symptoms of coronavirus disease 2019 and 3 false-negative results of nasopharyngeal swabs for molecular testing. We review and discuss the uncertain clinical characteristics of current severe acute respiratory syndrome coronavirus 2 molecular testing and the implications of false-negative results in the obstetrical population.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pregnancy Complications, Infectious
/
Obstetrics and Gynecology Department, Hospital
/
Bronchoalveolar Lavage Fluid
/
Infection Control
/
False Negative Reactions
/
COVID-19 Testing
/
SARS-CoV-2
/
COVID-19
Type of study:
Case report
/
Diagnostic study
/
Observational study
/
Prognostic study
Limits:
Adult
/
Female
/
Humans
/
Pregnancy
Language:
English
Journal:
Am J Obstet Gynecol MFM
Year:
2020
Document Type:
Article
Affiliation country:
J.ajogmf.2020.100130
Similar
MEDLINE
...
LILACS
LIS